​​Updated August 27, 2026

​

• NEW PUBLICATION: Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer    https://doi.org/10.64898/2026.07.05.735339

​

• NEW PUBLICATION: Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma    https://doi.org/10.1158/0008-5472.CAN-25-0018 

​​

• Featured by the MCW Cancer Center: Drugging the Undruggable: McFall Lab Unlocks New Treatments for KRAS-Driven Cancers.